Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 1,425,941 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 796,507 | N/A | N/A |
| Other Working Capital | N/A | N/A | -517,295 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 202,847 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $1,908,000 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -2,036,809 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-2,036,809 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -148,877 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 481,676 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $332,799 | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | 2,715 | N/A | N/A |
| Beginning Cash Position | N/A | N/A | 586,921 | N/A | N/A |
| End Cash Position | N/A | N/A | 793,626 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $206,705 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 1,908,000 | N/A | N/A |
| Free Cash Flow | 0 | 0 | 1,908,000 | 0 | 0 |